Although there is no one arguing that the stock pr
Post# of 30028
Let's focus on the last word we got from the company earlier this month.
Quote:
Next Steps for Amarantus
Uplist to NASDAQ as rapidly as possible
Focus on Operational Excellence with therapeutic programs
to advance to key data milestones
Complete strategic transaction with Amarantus Diagnostics
We are prepared to enter our next phase of growth!
I think they are working hard on the strategic transaction and they will uplist following September 4.
And the price will react accordingly.